Rare Parapneumonic Effusion Caused by Multidrug-Resistant Cronobactersakazakii: A Case of Successful Treatment with Two-Week Course of Antibiotic Therapy
IntroductionCronobactersakazakii, an opportunistic gram-negative bacillus, is known to induce meningitis in preterm infants, and enterocolitis and bacteremia in neonates and adults. However, the literature lacks documentation of parapneumonic effusion caused by this pathogen in adult patients. Case Presentation A 42-year-old male with a complex medical history, including chronic kidney disease, hypertensive cardiovascular disease, coronary artery disease, and type 2 diabetes mellitus, further complicated by a history of bilateral pleural effusion secondary to nephrosis requiring chest tube thoracostomy. He presented with a four-day history of productive cough and dyspnea. Initial evaluation and management focused on the fatal arrhythmia and subsequent encephalopathy, leading to intubation and extended hospitalization. The clinical course was further complicated by pneumonia and recurrence of pleural effusion, from which multidrug-resistant C. sakazakii was isolated using the conventional culture method. A two-week course of carbapenem and monobactam therapy yielded a favorable clinical outcome and resolution of the parapneumonic effusion. Conclusion This case report describes the first documented occurrence of multidrug-resistant C. sakazakii-induced parapneumonic effusion in a patient with complex comorbidities. Notably, a two-week antibiotic course effectively resolved the effusion, precluding the need for a more invasive surgical intervention.
References
[1]
Patrick, M.E., Mahon, B.E., Greene, S.A., Rounds, J., Cronquist, A., Wymore, K., et al. (2014) Incidence of Cronobacter spp. Infections, United States, 2003-2009. Emerging Infectious Diseases, 20, 1536-1539. https://doi.org/10.3201/eid2009.140545
[2]
Tall, B., Gangiredla, J., Grim, C., Patel, I., Jackson, S., Mammel, M., et al. (2017) Use of a Pan-Genomic DNA Microarray in Determination of the Phylogenetic Relatedness among Cronobacter Spp. and Its Use as a Data Mining Tool to Understand Cronobacter Biology. Microarrays, 6, Article 6. https://doi.org/10.3390/microarrays6010006
[3]
Healy, B., Cooney, S., O’Brien, S., Iversen, C., Whyte, P., Nally, J., et al. (2010) Cronobacter (Enterobacter sakazakii): An Opportunistic Foodborne Pathogen. Foodborne Pathogens and Disease, 7, 339-350. https://doi.org/10.1089/fpd.2009.0379
[4]
Lepuschitz, S., Ruppitsch, W., Pekard-Amenitsch, S., Forsythe, S.J., Cormican, M., Mach, R.L., et al. (2019) Multicenter Study of Cronobactersakazakii Infections in Humans, Europe, 2017. Emerging Infectious Diseases, 25, 515-522. https://doi.org/10.3201/eid2503.181652
[5]
Chen, W., Yang, J., You, C. and Liu, Z. (2016) Diversity of Cronobacter spp. Isolates from the Vegetables in the Middle-East Coastline of China. World Journal of Microbiology and Biotechnology, 32, Article No. 90. https://doi.org/10.1007/s11274-016-2033-4
[6]
Jaradat, Z.W., Al Mousa, W., Elbetieha, A., Al Nabulsi, A. and Tall, B.D. (2014) Cronobacter spp.—Opportunistic Food-Borne Pathogens. A Review of Their Virulence and Environmental-Adaptive Traits. Journal of Medical Microbiology, 63, 1023-1037. https://doi.org/10.1099/jmm.0.073742-0
[7]
Timsit, J., Wicky, P. and de Montmollin, E. (2022) Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients. Antibiotics, 11, Article 144. https://doi.org/10.3390/antibiotics11020144
[8]
Corcoran, J., Rahman, N. and Psallidas, I. (2014) Management of Parapneumonic Effusions and Empyema. Seminars in Respiratory and Critical Care Medicine, 35, 715-722. https://doi.org/10.1055/s-0034-1395503
[9]
Ferguson, A.D., Prescott, R.J., Selkon, J.B., Watson, D. and Swinburn, C.R. (1996) The Clinical Course and Management of Thoracic Empyema. QJM, 89, 285-290. https://doi.org/10.1093/qjmed/89.4.285
[10]
Grijalva, C.G., Zhu, Y., Nuorti, J.P. and Griffin, M.R. (2011) Emergence of Parapneumonic Empyema in the USA. Thorax, 66, 663-668. https://doi.org/10.1136/thx.2010.156406
[11]
Rahman, N.M., Maskell, N.A., West, A., Teoh, R., Arnold, A., Mackinlay, C., et al. (2011) Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection. New England Journal of Medicine, 365, 518-526. https://doi.org/10.1056/nejmoa1012740
[12]
Daikos, G.L. and Markogiannakis, A. (2011) Carbapenemase-Producing Klebsiella pneumoniae: (When) Might We Still Consider Treating with Carbapenems? Clinical Microbiology and Infection, 17, 1135-1141. https://doi.org/10.1111/j.1469-0691.2011.03553.x
[13]
Alsonosi, A., Hariri, S., Kajsík, M., Oriešková, M., Hanulík, V., Röderová, M., et al. (2015) The Speciation and Genotyping of Cronobacter Isolates from Hospitalised Patients. European Journal of Clinical Microbiology & Infectious Diseases, 34, 1979-1988. https://doi.org/10.1007/s10096-015-2440-8
[14]
LAI, K.K. (2001) Enterobacter sakazakii Infections among Neonates, Infants, Children, and Adults. Medicine, 80, 113-122. https://doi.org/10.1097/00005792-200103000-00004
[15]
Forsythe, S.J. (2018) Updates on the Cronobacter Genus. Annual Review of Food Science and Technology, 9, 23-44. https://doi.org/10.1146/annurev-food-030117-012246
[16]
Ravisankar, S., Syed, S.S., Garg, P. and Higginson, J. (2014) Is Cronobactersakazakii Infection Possible in an Exclusively Breastfed Premature Neonate in the Neonatal Intensive Care Unit? Journal of Perinatology, 34, 408-409. https://doi.org/10.1038/jp.2014.14
[17]
Sahra, S., Jahangir, A., Mobarakai, N., Glaser, A., Jahangir, A. and Sharif, M.A. (2021) First Case Report of Acute Cholangitis Secondary to Cronobactersakazakii. BMC Infectious Diseases, 21, Article No. 493. https://doi.org/10.1186/s12879-021-06195-4
[18]
Beuchat, L.R., Kim, H., Gurtler, J.B., Lin, L., Ryu, J. and Richards, G.M. (2009) Cronobactersakazakii in Foods and Factors Affecting Its Survival, Growth, and Inactivation. International Journal of Food Microbiology, 136, 204-213. https://doi.org/10.1016/j.ijfoodmicro.2009.02.029
[19]
Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E. and Courvalin, P. (2007) Modes and Modulations of Antibiotic Resistance Gene Expression. Clinical Microbiology Reviews, 20, 79-114. https://doi.org/10.1128/cmr.00015-06
[20]
Xu, X., Li, C., Wu, Q., Zhang, J., Huang, J. and Yang, G. (2015) Prevalence, Molecular Characterization, and Antibiotic Susceptibility of Cronobacter spp. in Chinese Ready-To-Eat Foods. International Journal of Food Microbiology, 204, 17-23. https://doi.org/10.1016/j.ijfoodmicro.2015.03.003
[21]
Holý, O., Parra-Flores, J., Lepuschitz, S., Alarcón-Lavín, M.P., Cruz-Córdova, A., Xicohtencatl-Cortes, J., et al. (2020) Molecular Characterization of Cronobactersakazakii Strains Isolated from Powdered Milk. Foods, 10, Article 20. https://doi.org/10.3390/foods10010020
[22]
Elshamy, A.A. and Aboshanab, K.M. (2020) A Review on Bacterial Resistance to Carbapenems: Epidemiology, Detection and Treatment Options. Future Science OA, 6, Article ID: FSO438. https://doi.org/10.2144/fsoa-2019-0098
[23]
Benbouza, A., Kassah-Laouar, A., Chelaghma, W., Bouziane, F., Mebarki, Y., Rolain, J., et al. (2024) Epidemiological and Genetic Characteristics of Clinical Carbapenemase-Producing Enterobacterales Isolates from Batna Hospitals in Algeria. BMC Infectious Diseases, 24, Article No. 1439. https://doi.org/10.1186/s12879-024-10300-8
[24]
Bouganim, R., Dykman, L., Fakeh, O., Motro, Y., Oren, R., Daniel, C., et al. (2020) The Clinical and Molecular Epidemiology of Noncarbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae: A Case-Case-Control Matched Analysis. Open Forum Infectious Diseases, 7, ofaa299. https://doi.org/10.1093/ofid/ofaa299
[25]
Palacios-Baena, Z.R., Giannella, M., Manissero, D., Rodríguez-Baño, J., Viale, P., Lopes, S., et al. (2021) Risk Factors for Carbapenem-Resistant Gram-Negative Bacterial Infections: A Systematic Review. Clinical Microbiology and Infection, 27, 228-235. https://doi.org/10.1016/j.cmi.2020.10.016
[26]
Marimuthu, K., Ng, O.T., Cherng, B.P.Z., Fong, R.K.C., Pada, S.K., De, P.P., et al. (2019) Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 63, e00845-19. https://doi.org/10.1128/aac.00845-19
[27]
Peri, A.M., Doi, Y., Potoski, B.A., Harris, P.N.A., Paterson, D.L. and Righi, E. (2019) Antimicrobial Treatment Challenges in the Era of Carbapenem Resistance. Diagnostic Microbiology and Infectious Disease, 94, 413-425. https://doi.org/10.1016/j.diagmicrobio.2019.01.020
[28]
Yasmin, M., Fouts, D.E., Jacobs, M.R., Haydar, H., Marshall, S.H., White, R., et al. (2019) Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1. Clinical Infectious Diseases, 71, 1095-1098. https://doi.org/10.1093/cid/ciz1155
[29]
Mauri, C., Maraolo, A.E., Di Bella, S., Luzzaro, F. and Principe, L. (2021) The Revival of Aztreonam in Combination with Avibactam against Metallo-Β-Lactamase-Producing Gram-Negatives: A Systematic Review of in Vitro Studies and Clinical Cases. Antibiotics, 10, Article 1012. https://doi.org/10.3390/antibiotics10081012
[30]
Chibabhai, V., Nana, T., Bosman, N., Thomas, T. and Lowman, W. (2017) Were All Carbapenemases Created Equal? Treatment of NDM-Producing Extensively Drug-Resistant Enterobacteriaceae: A Case Report and Literature Review. Infection, 46, 1-13. https://doi.org/10.1007/s15010-017-1070-8
